Page 19 - TD-3-2

Tumor Discovery Volatile organic compounds for cancer screening

doi: 10.1136/gutjnl-2015-310912 Chem. 2014;406(19):4757-4763.
26. Siegel RL, Wagle NS, Cercek A, et al. Colorectal cancer doi: 10.1007/s00216-014-7865-x
statistics, 2023. CA Cancer J Clin. 2023;73(3):233-254.
36. Altomare DF, Di Lena M, Porcelli F, et al. Effects of curative
doi: 10.3322/caac.21772 colorectal cancer surgery on exhaled volatile organic
compounds and potential implications in clinical follow-up.
27. Dozois EJ, Boardman LA, Suwanthanma W, et al. Young-
onset colorectal cancer in patients with no known genetic Ann Surg. 2015;262(5):862-867.
predisposition: Can we increase early recognition and doi: 10.1097/SLA.0000000000001471
improve outcome? Medicine (Baltimore). 2008;87(5):259-263.
37. Amal H, Leja M, Funka K, et al. Breath testing as
doi: 10.1097/MD.0b013e3181881354 potential colorectal cancer screening tool. Int J Cancer.
2016;138(1):229-236.
28. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA,
Jemal A. Global cancer statistics 2018: GLOBOCAN doi: 10.1002/ijc.29701
estimates of incidence and mortality worldwide for 36 38. Catalona WJ, Southwick PC, Slawin KM, et al. Comparison
cancers in 185 countries [published correction appears of percent free PSA, PSA density, and age-specific PSA
in CA Cancer J Clin. 2020;70(4):313]. CA Cancer J Clin. cutoffs for prostate cancer detection and staging. Urology.
2020;68(6):394-424.
2000;56(2):255-260.
doi: 10.3322/caac.21492
doi: 10.1016/s0090-4295(00)00637-3
29. Song LL, Li YM. Current noninvasive tests for colorectal 39. Wolf AMD, Wender RC, Etzioni RB, et al. American Cancer
cancer screening: An overview of colorectal cancer screening Society guideline for the early detection of prostate cancer:
tests. World J Gastrointest Oncol. 2016;8(11):793-800.
Update 2010. CA Cancer J Clin. 2010;60(2):70-98.
doi: 10.4251/wjgo.v8.i11.793
doi: 10.3322/caac.20066
30. Shapiro JA, Bobo JK, Church TR, et al. A comparison 40. Mason RJ, Marzouk K, Finelli A, et al. UPDATE - 2022
of fecal immunochemical and high-sensitivity guaiac Canadian Urological Association recommendations on
tests for colorectal cancer screening. Am J Gastroenterol. prostate cancer screening and early diagnosis Endorsement
2017;112(11):1728-1735.
of the 2021 Cancer Care Ontario guidelines on prostate
doi: 10.1038/ajg.2017.285 multiparametric magnetic resonance imaging. Can Urol
Assoc J. 2022;16(4):E184-E196.
31. Zauber AG, Knudsen AB, Carolyn R, et al. 178 Evaluating
the benefits and harms of colorectal cancer screening doi: 10.5489/cuaj.7851
strategies: A collaborative modeling approach to inform 41. Eastham JA, Auffenberg GB, Barocas DA, et al. Clinically
the US preventive services task force. Gastroenterology. localized prostate cancer: AUA/ASTRO guideline, Part II:
2016;150(4):S46-S46.
Principles of active surveillance, principles of surgery, and
doi: 10.1016/S0016-5085(16)30279-7 follow-up. J Urol. 2022;208(1):19-25.
32. Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of doi: 10.1097/JU.0000000000002758
benefits, burden, and harms of colorectal cancer screening 42. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of
strategies: Modeling study for the US preventive services prostate cancer among men with a prostate-specific antigen
task force. JAMA. 2016;315(23):2595-2609.
level < or =4.0 ng per milliliter [published correction
doi: 10.1001/jama.2016.6828 appears in N Engl J Med. 2004;351(14):1470]. N Engl J Med.
2004;350(22):2239-2246.
33. Adler A, Geiger S, Keil A, et al. Improving compliance to
colorectal cancer screening using blood and stool based tests doi: 10.1056/NEJMoa031918
in patients refusing screening colonoscopy in Germany. 43. Naughton CK, Miller DC, Mager DE, Ornstein DK,
BMC Gastroenterol. 2014;14:183.
Catalona WJ. A prospective randomized trial comparing 6
doi: 10.1186/1471-230X-14-183 versus 12 prostate biopsy cores: Impact on cancer detection.
J Urol. 2000;164(2):388-392.
34. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer
screening: Recommendations for physicians and patients 44. Khalid T, Aggio R, White P, et al. Urinary volatile organic
from the U.S. multi-society task force on colorectal cancer. compounds for the detection of prostate cancer. PLoS One.
Am J Gastroenterol. 2017;112(7):1016-1030. 2015;10(11):e0143283.
doi: 10.1038/ajg.2017.174 doi: 10.1371/journal.pone.0143283
35. Wang C, Ke C, Wang X, et al. Noninvasive detection of 45. Andriole GL, Bostwick DG, Brawley OW, et al. Effect of
colorectal cancer by analysis of exhaled breath. Anal Bioanal dutasteride on the risk of prostate cancer. N Engl J Med.

Volume 3 Issue 2 (2024) 13 doi: 10.36922/td.2061